Sio Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Sio Capital Management’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-97,616	Closed	-$412K	–	59
2023 Q4	$412K	Hold	97,616	–	–	0.09%	35
2023 Q3	$422K	Sell	97,616 -4,912	-5%	-$27.3K	0.13%	44
2023 Q2	$676K	Sell	102,528 -21,269	-17%	-$136K	0.17%	37
2023 Q1	$841K	Sell	123,797 -12,528	-9%	-$88.1K	0.42%	34
2022 Q4	$1.01M	Sell	136,325 -352,640	-72%	-$3.43M	0.37%	33
2022 Q3	$4.83M	Hold	488,965	–	–	1.54%	16
2022 Q2	$5.33M	Buy	488,965 +326,487	+201%	+$3.38M	2%	18
2022 Q1	$1.84M	Buy	+162,478	New	+$2.14M	0.61%	38
2020 Q4	–	Sell	-209,205	Closed	-$2.02M	–	108
2020 Q3	$2.02M	Buy	209,205 +65,091	+45%	+$696K	0.4%	58
2020 Q2	$1.65M	Sell	144,114 -577,079	-80%	-$6.53M	0.48%	53
2020 Q1	$7.47M	Buy	+721,193	New	+$8.94M	2.5%	14

Other funds holding VNDA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sio Capital Management's VNDA Position: Q1 2024 in Review

Sio Capital Management sold out of Vanda Pharmaceuticals (VNDA) in Q1 2024, closing a stake of 97,616 shares — an estimated $412K sold.

Sio Capital Management first reported a position in VNDA in Q1 2020 and held it in 11 quarters. The position peaked at $7.47M in Q1 2020. 144 funds tracked by Wall St. Rank hold VNDA as of Q1 2024.

Sio Capital Management reported no remaining Vanda Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
Sio Capital Management sold 97,616 Vanda Pharmaceuticals shares in Q1 2024, an estimated $412K.
Sio Capital Management first reported a position in Vanda Pharmaceuticals in Q1 2020 and held it in 11 quarters.
Sio Capital Management's Vanda Pharmaceuticals position peaked at $7.47M in Q1 2020.
144 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2024.

Based on Sio Capital Management's 13F filing for Q1 2024, filed 15 May 2024.